Healthcare Stocks In Focus On Latest CBO Report
Zacks Investment Research | Jul 19, 2017 09:25PM ET
Healthcare stocks are back in focus as the “Repeal and Replace Obamacare” scenario plays out. A lot has been happening in this part of the medical sector with efforts to “Repeal and Replace Obamacare” not meeting with much success and basically collapsing.
A quick look at the events that have unfolded over the past few months shows that “Repeal and Replace Obamacare” has been a key goal for President Trump who had said that his first course of action, once elected, for Obamacare would be to ask Congress to repeal it immediately. However, the President and Republican party leaders first suffered a setback in March this year with a healthcare bill (the American Healthcare Act or Trumpcare) being pulled from the House floor when it became clear that there would not be enough votes to pass the bill.
Then in June, the Senate issued its version, the Better Care Reconciliation Act of 2017, with certain changes being made -- however, four Republican Senators (Sens. Rand Paul, Ted Cruz, Ron Johnson, and Mike Lee) issued a joint statement saying that they were not ready to vote for the bill due to several reasons but were open to negotiation and obtaining more information before the bill was brought to the floor. While the Senators acknowledged that the draft bill was an improvement to the current health care system, they noted that it did not appear to accomplish the goal of repealing Obamacare and making health care more affordable.
Last week, the Senate came out with a revised version of its bill but this too failed to garner full support with Senators Mike Lee and Jerry Moran announcing earlier this week that they will not vote for the current version of the bill. Moreover, moderate senators were concerned by the cuts to Medicaid.
Repeal Now, Replace Later
With efforts to “Repeal and Replace Obamacare” failing, the focus has now shifted to repealing Obamacare without an immediate replacement -- the Obamacare Repeal Reconciliation Act of 2017. But what will the repercussions be if such a move is taken?
According to a report issued by the Congressional Budget Office (CBO) yesterday, enacting this legislation would cut federal deficits by $473 billion over the coming decade. However, the number of uninsured people would go up by 17 million in 2018 and average premiums in the nongroup market would increase by about 25%.
Once the ACA’s expansion of eligibility for Medicaid and subsidies for insurance purchased through the marketplaces established by the ACA are eliminated, the number of uninsured Americans would go up by 27 million in 2020 with premiums rising about 50%. 2026 would see the uninsured go up by 32 million with premiums doubling compared to the current law. Given these numbers, it doesn’t seem likely that “Repeal Now, Replace Later” will get much support.
Get The News You Want
Impact on Healthcare Stocks
As the “Repeal Now, Replace Later” scenario plays out, hospital and insurance stocks will remain in the limelight. Insurance stocks have had a very strong run so far in 2017 with the Zacks-categorized the complete list of today’s Zacks #1 Rank stocks here .
Hospital stocks have also had a pretty decent run so far this year though this sector will be under pressure if Obamacare gets repealed without a suitable replacement. This is because hospitals benefited under Obamacare with more than 20 million people gaining coverage. Repealing and/or replacing Obamacare without a suitable replacement would result in a significant increase in the uninsured population which does not bode well for hospitals. The Zacks-categorized Medical-Hospital industry is currently among the bottom 30% of the Zacks-ranked industries.
With healthcare reform expected to remain a key topic of discussion, expect volatility and uncertainty in this corner of the healthcare market in the near-term.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.